Jellagen Limited

Jellagen Limited is an ISO13485:2016 certified marine biotechnology company manufacturing a next generation collagen Type 0 derived from jellyfish (CT0). Purified Collagen Type-0 offers a biochemically ancient framework that is advantageous in terms of sustainability, technical utility and superior biological safety compared to traditional mammalian-sourc...

High precision inkjet bioprinting has the potential to improve critical biomedical research, whilst replacing/reducing reliance on animal testing. Currently, the precision of bioprinting platforms for the research sector is limited and incapable of recreating complex architectures visualised _in vivo_ efficiently, with batch-to-batch consistency, for a ti...

The immediate concern for the Covid-19 pandemic is naturally the fate of patients suffering infection. But the disease may have long term consequences for the health of some who survive the initial infection. Covid-19 is primarily associated with damage to the lungs and respiratory distress, and there are increasing reports that some patients who recover ...

The project is based around developing a novel wound management dressing to combat biofilm formation and promote wound healing, allowing chronic wounds to be addressed more effectively and increasing the wound healing success rate. Biofilms are a major problem in chronic wounds and the reasons that these infections evade antibiotics and host defences are ...

The project focuses on the creation of wound healing devices constructed primarily from jellyfish collagen. Chronic wounds are a global problem that put a large burden to health care services around the world, both financially and physically, and can severely affect quality of life. There is a need for products that can effectively heal chronic wounds, as...

Biofilms are present in chronic wounds and are known to contribute to continued infection and inflammation with antibiotic resistance of biofilms complicating the problem. Current wound healing treatments are associated with antibiotic resistance and often use mammalian (bovine) collagen treatments, which risks contamination from disease causing agents su...

Jellagen Pty Ltd (JPL) aims to conduct a Proof of Concept research project into the functionalisation of collagen and its fabrication into novel wound healing devices. The project aims to evaluate the potential of incorporating functionalised collagen into wound healing devices for a range of applications including the treatment of diabetic foot ulcers (D...

Jellagen Pty Ltd is a Med-tech and Healthcare company producing medical grade collagen sourced from jellyfish, a sustainable and novel source of collagen biomaterials. During our collagen extraction process, an unidentified rare protein is lost in our waste water system. Our idea is to formally characterise this protein, assess the viability of extracting...

Jellagen Pty Ltd (JPL) aims to conduct a Proof of Concept research project to optimise and refine the processing of jellyfish derived biomaterials to provide an efficient and cost effective route to manufacture a GMP and medical grade Type I and Type II collagen product for medical device & healthcare applications. The project aims to evaluate the potenti...